312 related articles for article (PubMed ID: 28842316)
1. Protease-activatable cell-penetrating peptide possessing ROS-triggered phase transition for enhanced cancer therapy.
Yoo J; Sanoj Rejinold N; Lee D; Jon S; Kim YC
J Control Release; 2017 Oct; 264():89-101. PubMed ID: 28842316
[TBL] [Abstract][Full Text] [Related]
2. Dual-responsive click-crosslinked micelles designed for enhanced chemotherapy for solid tumors.
Jin R; Sun J; Zhou L; Guo X; Cao A
Biomater Sci; 2020 May; 8(9):2507-2513. PubMed ID: 32211707
[TBL] [Abstract][Full Text] [Related]
3. Reactive oxygen species activated nanoparticles with tumor acidity internalization for precise anticancer therapy.
Deng H; Zhao X; Deng L; Liu J; Dong A
J Control Release; 2017 Jun; 255():142-153. PubMed ID: 28385677
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species responsive drug releasing nanoparticle based on chondroitin sulfate-anthocyanin nanocomplex for efficient tumor therapy.
Jeong D; Bae BC; Park SJ; Na K
J Control Release; 2016 Jan; 222():78-85. PubMed ID: 26686664
[TBL] [Abstract][Full Text] [Related]
5. pH triggered re-assembly of nanosphere to nanofiber: The role of peptide conformational change for enhanced cancer therapy.
Liang P; Zheng J; Dai S; Wang J; Zhang Z; Kang T; Quan C
J Control Release; 2017 Aug; 260():22-31. PubMed ID: 28522193
[TBL] [Abstract][Full Text] [Related]
6. Dual-responsive doxorubicin-loaded nanomicelles for enhanced cancer therapy.
Zhang X; Zhu T; Miao Y; Zhou L; Zhang W
J Nanobiotechnology; 2020 Sep; 18(1):136. PubMed ID: 32972412
[TBL] [Abstract][Full Text] [Related]
7. Exogenous Vitamin C-Triggered Surface Charge Conversion of pH/Reduction-Responsive Micelles for the Enhanced Tumor-Specific Activity of Loaded Doxorubicin.
Wu Z; Chen B; Gan Z; Chen F; Luo X
Mol Pharm; 2020 Mar; 17(3):954-964. PubMed ID: 31977226
[TBL] [Abstract][Full Text] [Related]
8. Disease-directed design of biodegradable polymers: Reactive oxygen species and pH-responsive micellar nanoparticles for anticancer drug delivery.
Leong J; Chin W; Ke X; Gao S; Kong H; Hedrick JL; Yang YY
Nanomedicine; 2018 Nov; 14(8):2666-2677. PubMed ID: 30017961
[TBL] [Abstract][Full Text] [Related]
9. Zinc finger-inspired nanohydrogels with glutathione/pH triggered degradation based on coordination substitution for highly efficient delivery of anti-cancer drugs.
Zhang Z; Wan J; Sun L; Li Y; Guo J; Wang C
J Control Release; 2016 Mar; 225():96-108. PubMed ID: 26812007
[TBL] [Abstract][Full Text] [Related]
10. Tumor-targeted micelle-forming block copolymers for overcoming of multidrug resistance.
Braunová A; Kostka L; Sivák L; Cuchalová L; Hvězdová Z; Laga R; Filippov S; Černoch P; Pechar M; Janoušková O; Šírová M; Etrych T
J Control Release; 2017 Jan; 245():41-51. PubMed ID: 27871991
[TBL] [Abstract][Full Text] [Related]
11. Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment.
Chen Y; Li H; Deng Y; Sun H; Ke X; Ci T
Acta Biomater; 2017 Mar; 51():374-392. PubMed ID: 28088668
[TBL] [Abstract][Full Text] [Related]
12. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
[TBL] [Abstract][Full Text] [Related]
13. Palmitoyl ascorbate and doxorubicin co-encapsulated liposome for synergistic anticancer therapy.
Yang Y; Lu X; Liu Q; Dai Y; Zhu X; Wen Y; Xu J; Lu Y; Zhao D; Chen X; Li N
Eur J Pharm Sci; 2017 Jul; 105():219-229. PubMed ID: 28526602
[TBL] [Abstract][Full Text] [Related]
14. Stepwise pH/reduction-responsive polymeric conjugates for enhanced drug delivery to tumor.
Yang S; Wang Y; Ren Z; Chen M; Chen W; Zhang X
Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():234-243. PubMed ID: 29025653
[TBL] [Abstract][Full Text] [Related]
15. Enhancing cancer targeting and anticancer activity by a stimulus-sensitive multifunctional polymer-drug conjugate.
Tu Y; Zhu L
J Control Release; 2015 Aug; 212():94-102. PubMed ID: 26113423
[TBL] [Abstract][Full Text] [Related]
16. Fullerene (C60)-based tumor-targeting nanoparticles with "off-on" state for enhanced treatment of cancer.
Shi J; Wang B; Wang L; Lu T; Fu Y; Zhang H; Zhang Z
J Control Release; 2016 Aug; 235():245-258. PubMed ID: 27276066
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Reactive Oxygen Species Generation by Mitochondria Targeting of Anticancer Drug To Overcome Tumor Multidrug Resistance.
Liu Y; Zhou Z; Lin X; Xiong X; Zhou R; Zhou M; Huang Y
Biomacromolecules; 2019 Oct; 20(10):3755-3766. PubMed ID: 31465208
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics evaluation of a thermosensitive chitosan based hydrogel containing liposomal doxorubicin.
Ren S; Dai Y; Li C; Qiu Z; Wang X; Tian F; Zhou S; Liu Q; Xing H; Lu Y; Chen X; Li N
Eur J Pharm Sci; 2016 Sep; 92():137-45. PubMed ID: 27388491
[TBL] [Abstract][Full Text] [Related]
19. Assembly of polymer micelles through the sol-gel transition for effective cancer therapy.
Khaliq NU; Oh KS; Sandra FC; Joo Y; Lee J; Byun Y; Kim IS; Kwon IC; Seo JH; Kim SY; Yuk SH
J Control Release; 2017 Jun; 255():258-269. PubMed ID: 28456679
[TBL] [Abstract][Full Text] [Related]
20. Chitosan derivatives functionalized dual ROS-responsive nanocarriers to enhance synergistic oxidation-chemotherapy.
Liao JX; Huang QF; Li YH; Zhang DW; Wang GH
Carbohydr Polym; 2022 Apr; 282():119087. PubMed ID: 35123755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
